Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TachoSil vs Surgicel Original for Soft Tissue Bleeding During Surgery
NCT06664775Phase 3Recruiting
- Sponsor
- Corza Medical
- Start
- Apr 2025
- Primary completion
- Dec 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of tachosil in hemorrhage (2 arms), sponsored by Corza Medical. Primary endpoint: Hemostatic success within 3 minutes. Started Apr 2025; status: recruiting.
02
Drugs
tachosil
03
Conditions
hemorrhage
Beyond the preview
Go deeper on NCT06664775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06664775.